Access to MedicinesMaking Innovation work

for the poor

Corinna Heineke

Diversity in InnovationEuropean Patent Conference, Brussels, 15/16 May 2007

Projected new cases of cancer by 2020

Source: WHO: World Cancer Report, 2006.

0

5

10

15

20

2000 2005 2010 2015 2020ne

w c

an

cer

case

s (m

illio

ns)

developing countries industrialized countries

TRIPS-Flexibilities

• Compulsory Licensing

• Parallel Importing

• Early-working (Bolar) provision

• Definition of novelty (e.g. India)

Novartis in India

• Cancer drug Glivec

• Novartis challenges both Patent ruling and Section 3(d) of.

• Potential effects on other developing countries

Solutions for access to medicinesfrom the corporate sector

• Voluntary Licensing

• Donation Programmes

• Tiered pricing – Differentiation between developed, developing and least-developed countries

Further solutions

• Medical Innovation Prize Funds

• Patent pooling

• Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (WHO)

• Drugs for Neglected Diseases Initiative

• (Advance Market Commitments)

Thank you!